Brief: Bioretec Updates Its Product Pipeline To Accelerate Commercialization Strategy
24/04/2023 12:01
April 24 (Reuters) - Bioretec Oy BRETEC.HE :
* INSIDE INFORMATION: BIORETEC UPDATES ITS PRODUCT PIPELINE
TO
ACCELERATE COMMERCIALIZATION STRATEGY FOLLOWING THE FIRST
REMEOS™ FDA MARKET AUTHORIZATION, AND CONSEQUENTLY UPDATES
FINANCIAL TARGETS
* NEW TARGET : TO REACH NET SALES OF EUR 62 MILLION BY END
OF YEAR
2027 (PREVIOUS TARGET: EUR 100 MILLION BY 2027)
* TARGET IS TO REACH POSITIVE CASH FLOW FROM OPERATING
ACTIVITIES
BY END OF YEAR 2026 (PREVIOUS TARGET: BY END OF 2025)
Source text for Eikon: ID:nWkr5DqKfN
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))